PHARMAZEUTISCHE FORMULIERUNGEN

Patent europeic · EP2205280 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2205280
Numer da la dumonda
EP08833819
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
29-09-2008
Publitgà
14-07-2010
Concedì
04-09-2019
La protecziun finescha il pli tard
28-09-2028
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
A61K 9/00 (2006.01)
A61K 47/22 (2006.01)
A61K 47/24 (2006.01)
A61K 39/395 (2006.01)
A61K 9/19 (2006.01)
A61K 47/18 (2017.01)
Prioritad
US 975780 P 27.09.2007
Dumonda PCT
PCT/US2008/078193 29.09.2008
Publicaziun PCT
WO2009/043049 02.04.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 01-10-2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. 03-10-2024

    Midada

    Published in Swissreg on 03.10.2024

  4. 01-10-2023

    Midada

    Published in Swissreg on 01.10.2023

  5. 01-10-2022

    Midada

    Published in Swissreg on 01.10.2022

  6. 04-09-2019

    Concedì

    Published in Swissreg on 04.09.2019

Partidas

Possessur

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US

Inventur

LI, Tiansheng

Newbury Park CA 91320, US

KO, Jason

Thousand Oaks CA 91360, US

VERGARA, Camille

Calabasas CA 91302, US

SLOEY, Christopher, James

Oak Park CA 91377, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.